CFG
AGIO icon

Citizens Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Citizens Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,478
Closed -$79K – 260
2020
Q2 		$79K Buy
1,478
+1,333
+919% +$61.7K 0.01% 394
2020
Q1 		$5K Hold
145
– – ﹤0.01% 855
2019
Q4 		$7K Buy
+145
New +$5.48K ﹤0.01% 802

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citizens Financial Group's AGIO Position: Q3 2020 in Review

Citizens Financial Group sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 1,478 shares — an estimated $79K sold.

Citizens Financial Group first reported a position in AGIO in Q4 2019 and held it in 3 quarters. The position peaked at $79K in Q2 2020. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Citizens Financial Group reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 1,478 Agios Pharmaceuticals shares in Q3 2020, an estimated $79K.
  • Citizens Financial Group first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Citizens Financial Group's Agios Pharmaceuticals position peaked at $79K in Q2 2020.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.